Verification of EZH2 as a druggable target in metastatic uveal melanoma

被引：0
|
作者：
Bei Jin
Ping Zhang
Hailin Zou
Huijing Ye
Yun Wang
Jing Zhang
Huasheng Yang
Jingxuan Pan
机构：
[1] Sun Yat-sen University,State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center
来源：
Molecular Cancer | / 19卷
关键词：
Uveal melanoma; EZH2; Hepatic metastasis; Motility; Cancer stem-like cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Verification of EZH2 as a druggable target in metastatic uveal melanoma
    Jin, Bei
    Zhang, Ping
    Zou, Hailin
    Ye, Huijing
    Wang, Yun
    Zhang, Jing
    Yang, Huasheng
    Pan, Jingxuan
    MOLECULAR CANCER, 2020, 19 (01)
  • [2] EZH2 as a novel therapeutic target in melanoma treatment
    Tiffen, Jessamy
    Gunatilake, Dilini
    Gallagher, Stuart
    Gowrishankar, Kavitha
    Hersey, Peter
    CANCER RESEARCH, 2014, 74 (19)
  • [3] The Tumorigenic Properties of EZH2 are Mediated by MiR-26a in Uveal Melanoma
    Li, Yao
    Zhang, Mingmei
    Feng, Huayin
    Mahati, Shaya
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [4] The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells
    Miele, Evelina
    Valente, Sergio
    Alfano, Vincenzo
    Silvano, Marianna
    Mellini, Paolo
    Borovika, Diana
    Marrocco, Biagina
    Po, Agnese
    Besharat, Zein Mersini
    Catanzaro, Giuseppina
    Battaglia, Giuseppe
    Abballe, Luana
    Zwergel, Clemens
    Stazi, Giulia
    Milite, Ciro
    Castellano, Sabrina
    Tafani, Marco
    Trapencieris, Peteris
    Mai, Antonello
    Ferretti, Elisabetta
    ONCOTARGET, 2017, 8 (40) : 68557 - 68570
  • [5] EZH2 copy number gain as a therapeutic target in mucosal melanoma
    Yu, Huan
    Kong, Yan
    Yan, Junya
    Ma, Meng
    Xu, Longwen
    Yu, Jiayi
    Xu, Tianxiao
    Dai, Jie
    Tang, Huan
    Wu, Xiaowen
    Chi, Zhihong
    Si, Lu
    Shen, Xinan
    Tang, Bixia
    Lian, Bin
    Wang, Xuan
    Li, Siming
    Bai, Xue
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target
    Cao, Jinfeng
    Pontes, Kelly C. S.
    Heijkants, Renier C.
    Brouwer, Niels J.
    Groenewoud, Arwin
    Jordanova, Ekaterina S.
    Marinkovic, Marina
    van Duinen, Sjoerd
    Teunisse, Amina F. A. S.
    Verdijk, Robert M.
    Snaar-Jagalska, Ewa
    Jochemsen, Aart G.
    Jager, Martine J.
    JOURNAL OF PATHOLOGY, 2018, 245 (04): : 433 - 444
  • [7] EZH2 -mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma
    Hou, Chen
    Xiao, Lirong
    Ren, Xiang
    Cheng, Lin
    Guo, Bo
    Zhang, Meixia
    Yan, Naihong
    FRONTIERS IN GENETICS, 2022, 13
  • [8] Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status
    Schoumacher, Marie
    Le Corre, Stephanie
    Houy, Alexandre
    Mulugeta, Eskeatnaf
    Stern, Marc-Henri
    Roman-Roman, Sergio
    Margueron, Raphal
    NATURE MEDICINE, 2016, 22 (06) : 577 - 578
  • [9] EZH2 inhibitors in immunotherapy of melanoma
    Hersey, Peter
    Gallagher, Stuart
    Tiffen, Jessamy
    Shklovskaya, Elena
    Wilson, Stephen
    Filipp, Fabian
    CANCER RESEARCH, 2017, 77
  • [10] Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status
    Marie Schoumacher
    Stéphanie Le Corre
    Alexandre Houy
    Eskeatnaf Mulugeta
    Marc-Henri Stern
    Sergio Roman-Roman
    Raphaël Margueron
    Nature Medicine, 2016, 22 : 577 - 578
12345